Concepedia

Publication | Closed Access

Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib

DOI

96

Citations

29

References

2016

Year

Atsushi Hiraoka, Masashi Hirooka, Yohei Koizumi, Hirofumi Izumoto, Hidetaro Ueki, Miho Kaneto, Shogo Kitahata, Toshihiko Aibiki, Hideomi Tomida, Yuji Miyamoto,
Hepatology Research

Abstract

Muscle wasting is an important prognostic factor in patients treated with sorafenib.

References

YearCitations

Page 1